FDA warns Cadila Pharma over drug production processes
Cadila Pharmaceuticals is the latest Indian drugmaker to face U.S. regulatory rebuke, as the FDA intensifies its scrutiny of the generic drugmakers.
Nov 12, 2014, 13:53 PM IST
generic drugmakers